Am J Gastroenterol
- SASAKI S, Schmidt S, Uldry E, Halkic N, et al
Hepaticocholecystic Duct: Not a Myth but a Pitfall in Cholecystectomy.
Am J Gastroenterol. 2024 Feb 19. doi: 10.14309/ajg.0000000000002725.
Biochem Biophys Res Commun
- KALISHWARALAL K, Azeez Nazeer A, Induja DK, Keerthana CK, et al
Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to
Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
Biochem Biophys Res Commun. 2024;703:149648.
- CHO W, Oh H, Abd El-Aty AM, Ozten O, et al
Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic
insights from an in vitro analysis.
Biochem Biophys Res Commun. 2024;703:149671.
BMC Cancer
- ZHANG N, Zhang H, Yang X, Xue Q, et al
USP14 exhibits high expression levels in hepatocellular carcinoma and plays a
crucial role in promoting the growth of liver cancer cells through the
HK2/AKT/P62 axis.
BMC Cancer. 2024;24:237.
- YUAN LX, Luo M, Liu RY, Wang HX, et al
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
BMC Cancer. 2024;24:239.
- ZHANG L, Sun T, Sun B, Zhang K, et al
Utility and predictive value of the CRAFITY score in advanced hepatocellular
carcinoma treated with transarterial chemoembolization plus tyrosine kinase
inhibitors and PD-1 inhibitor.
BMC Cancer. 2024;24:223.
- WANG K, Cui H, Zhu Y, Hu X, et al
Evaluation of an artificial intelligence-based clinical trial matching system in
Chinese patients with hepatocellular carcinoma: a retrospective study.
BMC Cancer. 2024;24:246.
- YUAN C, Zou S, Wang K, Hu Z, et al
Establishment and external validation of prognosis prediction nomogram for
patients with distant metastatic intrahepatic cholangiocarcinoma: based on a
large population.
BMC Cancer. 2024;24:227.
Cancer Res
- SONG M, Zhang C, Cheng S, Ouyang D, et al
DNA of neutrophil extracellular traps binds TMCO6 to impair CD8+ T-cell immunity
in hepatocellular carcinoma.
Cancer Res. 2024 Feb 21. doi: 10.1158/0008-5472.CAN-23-2986.
Dig Dis Sci
- ZHAO X, Guo X, Zhao Y, Yu Y, et al
Gastrointestinal Bleeding Was Diagnosed as Small Intestinal Metastasis of
Hepatocellular Carcinoma by Double-Balloon Enteroscopy.
Dig Dis Sci. 2024 Feb 21. doi: 10.1007/s10620-024-08339.
Endoscopy
- AMATA M, Boncori G, Scimeca D, Mocciaro F, et al
Hepatic fascioliasis: a rare case of "fake" biliary gallstones.
Endoscopy. 2024;56.
Eur Radiol
- ZHANG A, Meng X, Yao Y, Zhou X, et al
Head to head comparison of (68)Ga-DOTA-FAPI-04 vs (18)F-FDG PET/CT in the
evaluation of primary extrapulmonary tumors in the chest.
Eur Radiol. 2024;34:1960-1970.
- YOO J, Joo I, Jeon SK, Park J, et al
Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment
with CT attenuation-based parameters.
Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10660.
- CANNELLA R, Zins M, Brancatelli G
ESR Essentials: diagnosis of hepatocellular carcinoma-practice recommendations by
ESGAR.
Eur Radiol. 2024 Feb 21. doi: 10.1007/s00330-024-10606.
Gastrointest Endosc
- ISHIWATARI H, Ogura T, Hijioka S, Iwashita T, et al
Endoscopic ultrasound-guided hepaticogastrostomy versus hepaticogastrostomy with
antegrade stenting in patients with unresectable malignant distal biliary
obstruction: a propensity score-matched case-control study.
Gastrointest Endosc. 2024 Feb 19:S0016-5107(24)00109.
Gut
- EL-SERAG H, Kanwal F, Ning J, Powell H, et al
Serum biomarker signature is predictive of the risk of hepatocellular cancer in
patients with cirrhosis.
Gut. 2024 Feb 16:gutjnl-2024-332034. doi: 10.1136/gutjnl-2024-332034.
- LI R, Liu X, Huang X, Zhang D, et al
Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells
in colorectal cancer and their organ-specific metastasis.
Gut. 2023 Nov 30:gutjnl-2023-330243. doi: 10.1136/gutjnl-2023-330243.
Hepatology
- CALTHORPE L, Chiou SH, Rubin J, Huang CY, et al
A modified hospital frailty risk score for patients with cirrhosis undergoing
abdominal operations.
Hepatology. 2024 Feb 19. doi: 10.1097/HEP.0000000000000794.
- PREMKUMAR M, Kajal K, Izzy M, Sihag BK, et al
Reply to 'liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus".
Hepatology. 2024 Feb 16. doi: 10.1097/HEP.0000000000000792.
- PAPATHERODORIDIS G, Lampertico P
Hepatocellular carcinoma risk in HBeAg-positive chronic hepatitis B patients
under long-term nucleos(t)ide analogue therapy: New insights from Asia.
Hepatology. 2024 Feb 16. doi: 10.1097/HEP.0000000000000796.
- HE B, Huang Z, Qin S, Peng P, et al
Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth through inhibiting
Hippo signaling in hepatocellular carcinoma.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000783.
- PENG Z, Wei G, Huang P, Matta H, et al
ASK1/p38 axis inhibition blocks the release of mitochondrial "danger signals"
from hepatocytes and suppresses progression to cirrhosis and liver cancer.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000801.
- ENGELSKIRCHER SA, Chen PC, Strunz B, Oltmanns C, et al
Impending hepatocellular carcinoma diagnosis in cirrhotic patients after HCV cure
features a natural killer cell signature.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000804.
- HASSAN MM, Li D, Han Y, Byun J, et al
Genome-wide association study identifies high-impact susceptibility loci for
hepatocellular carcinoma in North America.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000800.
- WONG YJ, Teng M, Sim A, Thet HM, et al
Full adherence to cirrhosis quality indicators is associated with lower mortality
in acute variceal bleeding: Nationwide audit.
Hepatology. 2024 Feb 20. doi: 10.1097/HEP.0000000000000793.
- LEVY C, Dickey AK, Wang B, Thapar M, et al
Evidence-based consensus guidelines for the diagnosis and management of
protoporphyria-related liver dysfunction in erythropoietic protoporphyria and
X-linked protoporphyria.
Hepatology. 2024;79:731-743.
- LEDENKO M, Antwi SO, Patel T
Geospatial analysis of cyanobacterial exposure and liver cancer in the contiguous
United States.
Hepatology. 2024;79:575-588.
- BARTEN TRM, Atsma F, van der Meer AJ, Gansevoort R, et al
Higher need for polycystic liver disease therapy in female patients: Sex-specific
association between liver volume and need for therapy.
Hepatology. 2024;79:551-559.
- LEE BP, Dodge JL, Terrault NA
National prevalence estimates for steatotic liver disease and subclassifications
using consensus nomenclature.
Hepatology. 2024;79:666-673.
- WANG F, Chen L, Kong D, Zhang X, et al
Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an
LDH-A/HIF-1alpha transcriptional complex.
Hepatology. 2024;79:606-623.
- NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised
individual patient data meta-analysis.
Hepatology. 2024;79:624-635.
- LEVY C, Dickey AK, Anderson KE, Keel SB, et al
Reply: Contrasting effect of iron supplementation in protoporphyria.
Hepatology. 2024;79:E89-E90.
- BARMAN-AKSOZEN J, Minder AE, Schuppan D, Stolzel U, et al
Letter to the Editor: Contrasting effect of iron supplementation in
protoporphyria.
Hepatology. 2024;79:E87-E88.
- LAZARUS JV, Newsome PN, Francque SM, Kanwal F, et al
Reply: A multi-society Delphi consensus statement on new fatty liver disease
nomenclature.
Hepatology. 2024;79:E93-E94.
- HOOFNAGLE JH, Doo E
Letter to the Editor: A multi-society Delphi consensus statement on new fatty
liver disease nomenclature.
Hepatology. 2024;79:E91-E92.
Int J Cancer
- QIN XY, Shirakami Y, Honda M, Yeh SH, et al
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the
prevention of hepatocellular carcinoma recurrence.
Int J Cancer. 2024 Feb 21. doi: 10.1002/ijc.34893.
J Gastroenterol Hepatol
- WANG J, Zhang Y, Ma Y, Zhao S, et al
TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation.
J Gastroenterol Hepatol. 2024 Feb 18. doi: 10.1111/jgh.16443.
- BATT NM, Rodrigues B, Bloom S, Sawhney R, et al
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a
prospective study of characteristics and response to therapy.
J Gastroenterol Hepatol. 2024 Feb 18. doi: 10.1111/jgh.16501.
J Hepatol
- BOESCH M, Lindhorst A, Feio-Azevedo R, Brescia P, et al
Adipose tissue macrophage dysfunction is associated with a breach of vascular
integrity in NASH.
J Hepatol. 2024;80:397-408.
- BENDIXEN SM, Jakobsgaard PR, Hansen D, Hejn KH, et al
Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte
signaling module.
J Hepatol. 2024;80:467-481.
- IRUZUBIETA P, Santos-Laso A, Arias-Loste MT, Calleja JL, et al
Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD)
terminology in different clinical settings.
J Hepatol. 2024;80:e121-e123.
- LEE E, Korf H, Vidal-Puig A
Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease:
the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in
patients, but this might require developing and/or maintaining functionally
relevant level
J Hepatol. 2024;80:e112-e114.
- LARRUE H, Bureau C, D'Amico G
Reply to: "Comment on 'TIPS prevents further decompensation and improves survival
in patients with cirrhosis and portal hypertension in an individual patient data
meta-analysis'": Further decompensation should now be used as a clinically
relevant outc
J Hepatol. 2024;80:e109-e110.
- LIU Y, Chen M
Liver-adipose tissue crosstalk in non-alcoholic fatty liver disease: The emerging
role of remnant cholesterol.
J Hepatol. 2024;80:e111-e112.
- BLASZKIEWICZ J, Duncan SA
Use of stem cell-derived hepatocytes to model liver disease.
J Hepatol. 2024 Feb 15:S0168-8278(23)05306-0. doi: 10.1016/j.jhep.2023.
- CAON E, Martins M, Hodgetts H, Blanken L, et al
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic
stellate cells using 3D extracellular matrix models.
J Hepatol. 2024 Feb 14:S0168-8278(24)00110-7. doi: 10.1016/j.jhep.2024.
- NARDELLI S, Riggio O, Marra F, Gioia S, et al
Response to "Hepatic encephalopathy and survival after transjugular intra-hepatic
portosystemic shunt: do spontaneous portosystemic shunts matter?".
J Hepatol. 2024 Feb 14:S0168-8278(24)00122-3. doi: 10.1016/j.jhep.2024.
- YOUNOSSI ZM, Alqahtani SA, Alswat K, Yilmaz Y, et al
Global survey of stigma among physicians and patients with nonalcoholic fatty
liver disease.
J Hepatol. 2024;80:419-430.
- GE X, Desert R, Magdaleno F, Han H, et al
Redox-sensitive high-mobility group box-1 isoforms contribute to liver fibrosis
progression and resolution in mice.
J Hepatol. 2024;80:482-494.
- DIAZ LA, Fuentes-Lopez E, Idalsoaga F, Ayares G, et al
Association between public health policies on alcohol and worldwide cancer, liver
disease and cardiovascular disease outcomes.
J Hepatol. 2024;80:409-418.
- GAMBELLA A, Salvi M, Molinaro L, Patrono D, et al
Improved assessment of donor liver steatosis using Banff consensus
recommendations and deep learning algorithms.
J Hepatol. 2024;80:495-504.
- RUSSO FP, Francque SM, Shawcross DL, Krag AA, et al
Advocating for the implementation of the new nomenclature for steatotic liver
disease: A call to action for the national associations.
J Hepatol. 2024;80:384-386.
- HAXHE S, Baldin P, Trefois P, Havelange V, et al
Jaundice with severe leucocytosis.
J Hepatol. 2024;80:e103-e105.
J Pediatr
- ZIOGAS IA, Roach JP, Acker SN, Corkum KS, et al
Association of Sociodemographic Factors with Surgical Management of
Hepatoblastoma and Hepatocellular Carcinoma in Children.
J Pediatr. 2024 Feb 16:113963. doi: 10.1016/j.jpeds.2024.113963.
N Engl J Med
- KOWDLEY KV, Bowlus CL, Levy C, Akarca US, et al
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
Oncogene
- LI B, Xiong X, Xu J, Peng D, et al
METTL3-mediated m(6)A modification of lncRNA TSPAN12 promotes metastasis of
hepatocellular carcinoma through SENP1-depentent deSUMOylation of EIF3I.
Oncogene. 2024 Feb 19. doi: 10.1038/s41388-024-02970.
PLoS One
- NAIRZ J, Messner A, Kiechl SJ, Winder B, et al
Determinants of non-alcoholic fatty liver disease in young people: Maternal,
neonatal, and adolescent factors.
PLoS One. 2024;19:e0298800.
Radiol Artif Intell
- PRIOR O, Macarro C, Navarro V, Monreal C, et al
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine
Learning in Cancer.
Radiol Artif Intell. 2024 Jan 31:e230118. doi: 10.1148/ryai.230118.
Radiologia (Engl Ed)
- REDDY BURSAPALLE M, Valakkadaa J, Ayappan A
Role of intravoxel incoherent motion (IVIM) imaging in response assessment of
hepatocellular carcinoma after transarterial chemoembolization (TACE) - A
prospective study.
Radiologia (Engl Ed). 2024;66:23-31.
- ALONSO-GONZALEZ R, Abadal Villayandre JM, Galvez Gonzalez E, Alvarez Perez MJ, et al
Irreversible electroporation: Beyond the limits of tumor ablation.
Radiologia (Engl Ed). 2024;66:47-56.
Radiology
- CRIVELLARO P
A Deeper Look into Ancillary Features in LI-RADS Classification.
Radiology. 2024;310:e240251.
- DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma
and Malignancy: An Individual Participant Data Meta-Analysis.
Radiology. 2024;310:e231501.
Transplant Proc
- KIM SM, Yoon YI, Moon DB, Kim KH, et al
Achieving 400 Living Donor Liver Transplantations Annually During the COVID-19
Pandemic: A Single-Center Experience.
Transplant Proc. 2024 Jan 31:S0041-1345(23)00788.
- ISHII M, Hirukawa K, Shimata K, Yoshimaru Y, et al
The First Successful Living Donor Liver Transplantation for Acute-on-Chronic
Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report.
Transplant Proc. 2024 Jan 12:S0041-1345(23)00775.
Transplantation
- SEDKI M, Kwong A, Bhargava M, Ahmed A, et al
Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A
Comparative Assessment of Relapse Prediction Models.
Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004800.
- ROSENTHAL BE, Abt PL, Schaubel DE, Reddy KR, et al
Living Donor Liver Transplantation for Adults With High Model for End-stage Liver
Disease Score: The US Experience.
Transplantation. 2023 Aug 28. doi: 10.1097/TP.0000000000004767.
- BRANAGAN WT, Norvell JP
Assessment and Evaluation of Alcohol Use Disorder in Liver Transplant.
Transplantation. 2023 Jul 6. doi: 10.1097/TP.0000000000004722.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016